BICYCLIC HETEROCYCLIC COMPOUNDS AS FGFR INHIBITORS

摘要

The invention relates to bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of cancer, proliferative disorders, or a disease state or condition mediated by a FGFR kinase, the compound having the structure of Formula (I). (see formula I)